Please assess the completion status of the following clinical trial:

Trial Title: Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy male or female 21 years of age or older~* Scheduled to undergo standard cataract surgery with topical anesthesia in both eyes within 6-25 days between surgeries.~* Willing and able to administer eye drops and record the times the drops were instilled~* Understand and are willing to sign the Informed Consent form~* Willing to complete the entire course of the study.~Exclusion Criteria:~* Use of an eye medication or drops within 48 hours of the scheduled cataract surgery, other than the study medication or procedural solution required for surgery.~* Known sensitivity to any of the ingredients in the study medications or similar medications.~* Scheduled for 2nd eye cataract surgery earlier than 6 days or longer than 25 days apart.~* Corneal edema in either eye.~* Need for regional or general anesthesia during surgery.~* Complicated cataract surgery, including use of iris hooks or iris stretchers.~* Sight better than 20/100 in only one eye.~* A history of previous intraocular surgery in either eye.~* A history of uveitis, iritis, or intraocular inflammation.~* Macular pathology of the retina.~* Presence of glaucoma.~* Any confirmed or suspected active viral, bacterial, or fungal keratoconjunctival disease.~* History of steroid-related intraocular pressure (IOP) rise in the study eye.~* Lack of an intact corneal epithelium.~* Pupils that do not dilate to more than 5 mm prior to surgery or you require mechanical stretching of your pupil.~* Diabetes mellitus.~* Required use of a systemic steroidal or non-steroidal anti-inflammatory during the study period.~* Doctor has determined the presence of a condition (i.e., UNCONTROLLED systemic disease) or a situation that may put the subject at significant risk, confound the study results or may interfere significantly with your participation in the study.~* Females, who are pregnant, nursing an infant or planning a pregnancy.~* Currently involved in another investigational study or have participated in one within the 30 days prior to entering this study.~* Unable or unwilling to give signed informed consent prior to participation in any study-related procedures.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Difluprednate Ophthalmic Emulsion 0.05% (Type: ACTIVE_COMPARATOR): None
- Prednisolone acetate suspension 0.1% (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).